Loading clinical trials...
Loading clinical trials...
MRI With a Lymph Node Specific Contrast Agent: an Alternative for CT-Scanning and Lymph Node Dissection in Patients With Prostate Cancer?
Conditions
Interventions
Ferumoxtran-10 enhanced MRI (MRL)
Locations
3
Netherlands
NKI AVL
Amsterdam, Netherlands
Catharina Hospital
Eindhoven, Netherlands
Ziekenhuis Zeeuws-Vlaanderen
Terneuzen, Netherlands
Start Date
April 1, 2002
Completion Date
August 1, 2005
Last Updated
September 16, 2005
NCT07225946
NCT04868604
NCT00756665
NCT05743621
NCT04104776
NCT06242119
Lead Sponsor
Radboud University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions